Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

212
The pathophysiology of pneumonia involves the following steps:
212
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

153
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
153
Pneumonia IV: Management01:28

Pneumonia IV: Management

297
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
297
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Brain : a journal of neurology·2026
Same author

Genome-wide association study identifies <i>ABCG1</i> as a susceptibility locus for tick-borne encephalitis.

iScience·2025
Same author

Percutaneous Endobiliary Cryobiopsy in Biliary Obstruction: Randomised Study (BICRYOB).

Cardiovascular and interventional radiology·2025
Same author

Differentiating Brain Metastasis and High-Grade Glioma Using Multi-b Value Diffusion MRI and Tumor Volumetry.

Journal of neuroimaging : official journal of the American Society of Neuroimaging·2025
Same author

The utility of multi-b-value diffusion and arterial spin labelling magnetic resonance imaging in gliomas grading and prediction of isocitrate dehydrogenase status.

Quantitative imaging in medicine and surgery·2025
Same author

Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24.

BMC medicine·2025

Related Experiment Video

Updated: Jun 2, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

[Pneumocystis pneumonia].

Svatava Snopková1, Radek Svačinka, David Vydrář

  • 1Clinic of Infectious Diseases, Faculty of Medicine, Masaryk University, University Hospital Brno, Czech Repubic,

Klinicka Mikrobiologie a Infekcni Lekarstvi
|January 14, 2025
PubMed
Summary
This summary is machine-generated.

Secondary immunodeficiency increases opportunistic infections like pneumocystis pneumonia (PCP). Early diagnosis and treatment, considering coinfections, are vital for patient survival.

More Related Videos

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.0K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

364

Related Experiment Videos

Last Updated: Jun 2, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.0K
Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

364

Area of Science:

  • Infectious Diseases
  • Immunology
  • Pulmonology

Context:

  • Modern therapeutics increase survival but lead to secondary immunodeficiency.
  • Patients with secondary immunodeficiency face heightened risks of opportunistic infections.
  • Pneumocystis pneumonia (PCP) is a frequent, life-threatening infection in immunocompromised individuals.

Purpose:

  • To review the epidemiology, risk factors, pathophysiology, diagnosis, and management of PCP.
  • To highlight the expanding population at risk for PCP, including non-HIV patients.
  • To emphasize the importance of recognizing and treating coinfections, such as cytomegalovirus, in PCP cases.

Summary:

  • PCP incidence is rising in diverse patient groups, including those on chronic glucocorticoids.
  • Diagnosis is often delayed, contributing to high mortality rates.
  • Comprehensive management requires addressing underlying immune dysfunction and potential coinfections.

Impact:

  • Improved diagnostic strategies and timely treatment can reduce PCP-related mortality.
  • Increased awareness of PCP in non-traditional risk groups is crucial for prompt intervention.
  • Understanding coinfection dynamics is essential for effective PCP treatment and patient outcomes.